Related Experiment Video
Updated: Mar 7, 2026

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
The Effect of Remimazolam Administration on Emergence Delirium in Children After General Anesthesia: A Systematic
Ji-Na Kim1, Hyo-Seok Na1,2, Hyun-Jung Shin1,2
1Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Republic of Korea.
Insights
Remimazolam significantly reduces emergence delirium in children after anesthesia. This ultra-short-acting benzodiazepine also lowered bradycardia and improved recovery compared to propofol, without impacting overall stability.
Area of Science:
- Anesthesiology and Perioperative Medicine
- Pediatric Critical Care
Background:
- Emergence delirium is a common complication in pediatric patients post-general anesthesia.
- Remimazolam, an ultra-short-acting benzodiazepine, is a newer agent in pediatric anesthesia.
- Its efficacy in preventing emergence delirium requires thorough investigation.
Purpose of the Study:
- To systematically review and meta-analyze the impact of remimazolam on emergence delirium in pediatric patients.
- To evaluate the incidence and severity of emergence delirium.
- To assess secondary outcomes including hemodynamic stability and recovery parameters.
Main Methods:
- A comprehensive literature search was conducted across major databases (PubMed, EMBASE, CENTRAL, Scopus, Web of Science, Google Scholar).
- Ten randomized controlled trials (RCTs) involving 1231 children were included in the meta-analysis.
- Random-effects models were used to calculate relative risks and mean differences for primary and secondary outcomes.
Main Results:
- Remimazolam significantly reduced the incidence of emergence delirium (RR 0.38) and its severity (MD -1.70).
- A notable decrease in bradycardia (RR 0.39) was observed.
- While overall hypotension incidence did not differ, remimazolam showed lower rates than propofol in subgroup analysis. Extubation time was comparable overall but shorter versus propofol.
Conclusions:
- Remimazolam demonstrates potential in mitigating emergence delirium in pediatric patients undergoing general anesthesia.
- The agent appears to maintain hemodynamic stability and does not prolong recovery time.
- Further research may solidify remimazolam's role in pediatric anesthesia protocols.
Background:
Emergence delirium commonly occurs in pediatric patients after general anesthesia, causing distress and potential harm. Remimazolam, an ultra-short-acting benzodiazepine, has recently been introduced in pediatric anesthesia, but its preventive role against emergence delirium remains unclear.
Aims:
This systematic review with meta-analysis evaluated the effect of remimazolam on the incidence and severity of emergence delirium in children undergoing general anesthesia.
Methods:
PubMed, EMBASE, CENTRAL, Scopus, Web of Science, and Google Scholar were searched for relevant studies. The primary outcome was the incidence of emergence delirium. Secondary outcomes included Pediatric Anesthesia Emergence Delirium score, incidence of hypotension and bradycardia, extubation time, postanesthesia care unit stay, and postoperative nausea and vomiting incidence. Relative risks (RR) or mean difference (MD) with 95% confidence intervals (CI) were calculated using a random-effects model.
Results:
Ten randomized controlled trials involving 1231 children were included. Remimazolam significantly reduced the incidence of emergence delirium (RR 0.38, 95% CI 0.23-0.63; p = 0.0002) and Pediatric Anesthesia Emergence Delirium score (MD -1.70, 95% CI -2.77 to -0.63; p = 0.0019). It also decreased bradycardia (RR 0.39, 95% CI 0.21-0.70; p = 0.0018). Although the overall incidence of hypotension did not differ significantly (RR 0.35, p = 0.0991), subgroup analysis showed a lower incidence with remimazolam than with propofol (RR 0.14, p = 0.0376). Overall extubation time was comparable (MD -0.75, p = 0.5088), but shorter with remimazolam than propofol (MD -3.36, p < 0.0001). No significant differences were found in postanesthesia care unit stay or postoperative nausea and vomiting.
Conclusions:
Remimazolam may reduce the incidence and severity of emergence delirium in children after general anesthesia, without affecting hemodynamic stability or recovery time.
Trial Registration:
PROSPERO: CRD420251236789.
More Related Videos
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
03:02Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
Published on: July 25, 2025
Related Concept Videos
Parenteral Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Stages of General Anesthesia
REM Sleep Behavior Disorder
RBD is significantly associated with...
Inhalational Anesthetics: Overview